[Yung Shin] March 2026 Revenue NT$620 Million (YoY -23.7%)
Yung Shin Pharmaceutical announced its March 2026 monthly revenue was NT$620 million, a sharp decrease of 23.7% year-over-year. This indicates challenges in the biotechnology and medical care industry.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: April 12, 2026 at 16:30 (1015h 30m after Published)
- 🤖 AI Analyzed: April 12, 2026 at 21:21 (4h 51m after Collected)
Company Code: 3705
Company Name: Yung Shin
Industry: Biotechnology and Medical Care Industry
Data Month: 2026-03
Monthly Revenue: 620,239 thousand NTD (NT$620 million)
Year-over-Year Change: -23.7%
Company Name: Yung Shin
Industry: Biotechnology and Medical Care Industry
Data Month: 2026-03
Monthly Revenue: 620,239 thousand NTD (NT$620 million)
Year-over-Year Change: -23.7%